Holmes Scott A

Track

Insider profile

Holmes Scott A's trades of Keryx Biopharmaceuticals Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2018-11-16 2018-11-15
S Sale
83,783 -43.3%
151.69
US$4,038,226 		83,783 -43.3% 151.69 US$4,038,226
2018-10-30 2018-10-29
S Sale
45,323 +37.5%
449.84
US$1,944,493 		45,323 +37.5% 449.84 US$1,944,493
2018-08-16 2018-08-15
S Sale
80,627 -43.7%
116.42
US$4,826,297 		80,627 -43.7% 116.42 US$4,826,297
2018-07-31 2018-07-30
S Sale
2,354 -1.4%
3.86
US$9,086 		2,354 -1.4% 3.86 US$9,086
2018-05-16 2018-05-15
S Sale
1,158 -0.7%
5.69
US$6,589 		1,158 -0.7% 5.69 US$6,589
2018-05-01 2018-04-30
S Sale
2,407 -1.4%
4.67
US$11,241 		2,407 -1.4% 4.67 US$11,241
2018-02-16 2018-02-15
S Sale
5,651 -4.1%
4.81
US$27,181 		5,651 -4.1% 4.81 US$27,181
2018-01-31 2018-01-29
S Sale
2,830 -2.0%
4.81
US$13,612 		2,830 -2.0% 4.81 US$13,612
2017-10-31 2017-10-30
S Sale
2,582 -1.8%
6.03
US$15,569 		2,582 -1.8% 6.03 US$15,569
2017-08-01 2017-07-31
S Sale
1,445 -1.0%
7.14
US$10,317 		1,445 -1.0% 7.14 US$10,317
2017-07-31 2017-07-28
S Sale
1,236 -0.9%
6.96
US$8,603 		1,236 -0.9% 6.96 US$8,603
2017-05-03 2017-05-01
S Sale
1,441 -1.0%
5.97
US$8,603 		1,441 -1.0% 5.97 US$8,603
2017-05-01 2017-04-28
S Sale
1,219 -0.8%
5.89
US$7,180 		1,219 -0.8% 5.89 US$7,180